Keyword: George Scangos

Vir Biotechnology

Vir Biotechnology focuses on developing vaccines and drugs to cure infectious diseases for which there are currently scarce treatments. Though it hasn’t provided any details about its pipeline quite yet, its launch was remarkable for the sheer size of the funding: $150 million from ARCH Venture Partners.

FierceBiotech's 2017 Fierce 15

The philosophy of Fierce 15 is a simple one: We want to see the best science combined with the brightest teams, and we want to see the promise that they hold in their hands has a genuine chance of being the Next Big Thing. Here are this year's standouts.